Recent Advances in Parkinsons Disease: Part II: Translational and Clinical Research: 184 (Progress in Brain Research): Volume 184. Cet article n’est pas disponible.
Langue : anglais
Edité par Elsevier Science 2010-10-15, 2010
- Livre relié
- Neuf
Vendeur : Chiron Media, Wallingford, Royaume-UniChiron Media
Vendeur AbeBooks depuis 2 août 2010
Etat: Neuf
EUR 257,85
A propos de cet article
Brand new book, sourced directly from publisher. Dispatch time is 9-10 days from our warehouse. Book will be sent in robust, secure packaging to ensure it reaches you securely.
N° de réf. du vendeur 6666-ELS-9780444537508
- Titre
- Recent Advances in Parkinsons Disease: Part II: Translational and Clinical Research: 184 (Progress in Brain Research): Volume 184
- Auteur
- Anders Bjorklund Dr., Angela Cenci-Nilsson
- Éditeur
- Elsevier Science 2010-10-15
- Année de publication
- 2010
- État de l'article
- New
- Reliure
- Hardcover
- Langue
- anglais
- ISBN à 10 chiffres
- 0444537503
- ISBN à 13 chiffres
- 9780444537508
- Série
- Livre 50 sur 103: Progress in Brain Research
This second volume follows on from Part I by reviewing the variety of animal models of PD current available (from drosophila to rodents to non-human primate species) and their specific contributions to PD research. This is followed by comprehensive coverage of functional neuroimaging studies that explore different pathophysiological questions and evaluate treatment outcome in PD patients. Different areas of experimental therapeutics and outstanding challenges to PD treatment are presented in a concluding group of articles.
« Synopsis » peut appartenir à une autre édition de cet ouvrage.
À propos de l’auteur
Angela Cenci Nilsson (author name M. A. Cenci) is Professor of Experimental Medical Research at Lund University (Sweden) where she heads the Basal Ganglia Pathophysiology Group). The group's research activities address the pathophysiology and pharmacology of Parkinson's disease (PD) and L-DOPA-induced dyskinesia using a multidisciplinary and translational approach. Current projects span a large variety of topics, including synaptic dysfunctions, dopamine receptor signaling, gliovascular-neuronal interactions, and neurorestorative treatments to enhance function and plasticity in the damaged nigrostriatal pathway.
Angela has a combined clinical-basic science background, having graduated in Medicine and specialized in Neurology at the University of Verona (Italy) before obtaining a PhD degree in Neurobiology at Lund University under the supervision of Prof. Anders Björklund. In 2002 Angela received a tenured appointment as Associate Professor at Lund University, which was followed by an appointment as Full Professor in 2008.
Angela has pioneered the development of symptomatic models of parkinsonism and L-DOPA-induced dyskinesia in rodents, and exploited these models to discover cellular mechanisms of disease and new therapeutic approaches. For these research achievements, she has received several awards (such as, the Erik K. Fernström Award for Young Promising Investigators, the Medal of Honours for Parkinson´s Research by the Swedish Parkinson's Disease Foundation, and a recent membership in the Royal Academy for the Natural Sciences, Medicine and Technology in Lund). Angela currently serves on the scientific advisory boards and steering committees of several national and international research organizations, including the Swedish National Microscopy Infrastructure, The Swedish Parkinson's Research Foundation, the Swedish Brain Foundation, the International Association for Parkinsonism and Related Disorders (IAPDR), and the International Basal Ganglia Society (IBAGS).
« A propos de ce titre » peut appartenir à une autre édition de cet ouvrage.